Age | Date at recruitment minus date of birth | Years of age | Quantitative |
Gender | Male or female genotype of the person | Male/female | Qualitative nominal |
Weight | How much the patient weighs at the time of study inclusion | Weight, kilograms | Continuous quantitative |
Size | How tall is the patient from head to toe at the time of study inclusion | Height, centimetres | Continuous quantitative |
Body mass index | The division between weight by height squared at the time of inclusion in the study | Units of kg/cm2 | Continuous quantitative |
Occupation | Remunerative work performed by the participant at the time of recruitment | Unemployed, informal, unskilled employee, microentrepreneur or saleswoman, administrative employee, professional and entrepreneur | Qualitative nominal |
Civil status | Civil status of the individual | Married, single, widowed, divorced and common-law union | Qualitative nominal |
Level of study | Years completed and approved at the time of study recruitment | No studies, primary, secondary, preparatory, technical career, undergraduate and postgraduate | Ordinal qualitative |
Alcohol intake | Consumption of alcoholic beverages | Intake of alcoholic beverages | Qualitative nominal |
Smoking habit | Habitual tobacco uses at the time of recruitment | Number of packs of cigarettes consumed per day | Quantitative |
Drug’s use | Regular use of chemicals such as amphetamines, cocaine, marijuana, LSD, heroin and glass | Consumption of drugs | Qualitative nominal |
Hypertension | Elevation of blood pressure >130/80 | Positive/negative | Qualitative nominal |
Asthma | Chronic inflammatory disease characterised by bronchial hyperactivity with recurrent episodes of bronchospasm | Positive/negative | Qualitative nominal |
Diabetes | Group of metabolic diseases, which occurs when the pancreas does not produce enough insulin or when the body does not use the insulin it produces effectively | Positive/negative | Qualitative nominal |
Obesity | Pathological state characterised by a general excess or excessive accumulation of fat in the body | Positive/negative | Qualitative nominal |
SARS-CoV-2 pneumonia | A form of severe pneumonia caused by coronavirus | Positive/negative | Qualitative nominal |
Death | Statistical term that describes the death of an individual | Positive/negative | Qualitative nominal |
Intensive care unit | Special facility in a hospital area, which provides life support to critically ill patients, requiring intensive supervision and monitoring | Positive/negative | Qualitative nominal |
Severe pneumonia | Defined by the American Thoracic Society Criteria requiring at least one main criterion (need for invasive mechanical ventilation and shock with need for vasopressors), or three minor criteria (respiratory rate >30 bpm, PaO2/FiO2 ratio <250, infiltrates multilobars, confusion/disorientation, uremia (>20 mg/dL), leucopenia (<4000), thrombocytopaenia (<100 000 platelets/mm3), hypothermia (core temperature <36°C) or hypotension requiring aggressive fluid resuscitation | Positive/negative | Qualitative nominal |
Pneumonia | Acute infection of the lung parenchyma, accompanied by bilateral infiltrates on chest X-ray | Positive/negative | Qualitative nominal |
Confusion | Glasgow scale less than 15 | Positive/negative | Qualitative nominal |
Hypothermia | Body temperature less than 36°C | Positive/negative | Qualitative nominal |
Thrombocytopaenia | Total platelets less than 100 000 per mm3 | Positive/negative | Qualitative nominal |
Arterial hypotension | Systolic blood pressure less than 90 mm Hg or mean arterial pressure less than 60 mm Hg | Positive/negative | Qualitative nominal |
Sepsis | Rapid SOFA score (qSOFA) with two of the following three clinical variables: Glasgow ≤13, systolic pressure ≤100 mm Hg or respiratory rate ≥22 bpm | Positive/negative | Qualitative nominal |
qRT-PCR for SARS-CoV-2 | Molecular diagnosis for SARS-CoV-2 from viral RNA | Positive/negative | Qualitative nominal |
Septic shock | Arterial hypotension that persists after resuscitation volume and that requires vasopressors to maintain MAP (mean arterial pressure) ≥65 mm Hg and lactate ≥2 mmol/L (18 mg/dL) in the absence of hypovolaemia | Positive/negative | Qualitative nominal |
Adverse events related to the use of hydroxychloroquine | Indirect drug-related mortality, nausea, vomiting, abdominal pain, rash, itchy skin, hair loss, QT segment elongation on ECG, corneal opacity, cardiac arrhythmias and heart failure | Positive/negative | Qualitative nominal |
Adverse events related to the use of bromhexine | Indirect drug-related mortality, nausea, vomiting, abdominal pain, rash and diarrhoea | Positive/negative | Qualitative nominal |